Several new devices for the treatment of heart failure (HF) patients have been introduced and are increasingly used in clinical practice or are under clinical evaluation in either observational and/or randomized clinical trials. These devices include cardiac contractility modulation, spinal cord stimulation, carotid sinus nerve stimulation, cervical vagal stimulation, intracardiac atrioventricular nodal vagal stimulation, and implantable hemodynamic monitoring devices. This task force believes that an overview on these technologies is important. Special focus is given to patients with HF New York Heart Association Classes III and IV and narrow QRS complex, who represent the largest group in HF compared with patients with wide QRS complex. An overview on potential device options in addition to optimal medical therapy will be helpful for all physicians treating HF patients. © 2013 The Author.
New devices in heart failure: An European Heart Rhythm Association report / Kuck, Karl Heinz; Bordachar, Pierre; Borggrefe, Martin; Boriani, Giuseppe; Burri, Haran; Leyva, Francisco; Schauerte, Patrick; Theuns, Dominic; Thibault, Bernard; Kirchhof, Paulus; Hasenfuss, Gerhard; Dickstein, Kenneth; Leclercq, Christophe; Linde, Cecilia; Tavazzi, Luigi; Ruschitzka, Frank. - In: EUROPACE. - ISSN 1099-5129. - 16:1(2014), pp. 109-128. [10.1093/europace/eut311]
New devices in heart failure: An European Heart Rhythm Association report
BORIANI, Giuseppe;
2014-01-01
Abstract
Several new devices for the treatment of heart failure (HF) patients have been introduced and are increasingly used in clinical practice or are under clinical evaluation in either observational and/or randomized clinical trials. These devices include cardiac contractility modulation, spinal cord stimulation, carotid sinus nerve stimulation, cervical vagal stimulation, intracardiac atrioventricular nodal vagal stimulation, and implantable hemodynamic monitoring devices. This task force believes that an overview on these technologies is important. Special focus is given to patients with HF New York Heart Association Classes III and IV and narrow QRS complex, who represent the largest group in HF compared with patients with wide QRS complex. An overview on potential device options in addition to optimal medical therapy will be helpful for all physicians treating HF patients. © 2013 The Author.File | Dimensione | Formato | |
---|---|---|---|
VOR_New devices in heart failure An European Heart Rhythm Association report.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
1.05 MB
Formato
Adobe PDF
|
1.05 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris